+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Attention Deficit Disorder"

From
Mental Health Software Market - Global Forecast 2026-2032 - Product Thumbnail Image

Mental Health Software Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 196 Pages
  • Global
From
From
Mental Health Management Market - Global Strategic Business Report - Product Thumbnail Image

Mental Health Management Market - Global Strategic Business Report

  • Report
  • September 2026
  • 375 Pages
  • Global
From
From
Mental Health Technology Market Research Report 2025-2030 - Product Thumbnail Image

Mental Health Technology Market Research Report 2025-2030

  • Report
  • August 2025
  • 135 Pages
  • Global
From
UVB Light Therapy Device Market - Global Forecast 2025-2030 - Product Thumbnail Image

UVB Light Therapy Device Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 189 Pages
  • Global
From
From
From
Agoraphobia Market in China - Product Thumbnail Image

Agoraphobia Market in China

  • Report
  • February 2026
  • 162 Pages
  • China
From
From
From
Loading Indicator

Attention Deficit Disorder (ADD) is a mental health disorder characterized by difficulty focusing, impulsivity, and hyperactivity. It is most commonly diagnosed in children, but can also affect adults. Symptoms of ADD can include difficulty paying attention, difficulty organizing tasks, restlessness, and impulsivity. Treatment for ADD typically includes medication, psychotherapy, and lifestyle changes. The Attention Deficit Disorder market is a subset of the larger Mental Health market. It is a growing market, with an increasing number of people seeking treatment for ADD. The market is expected to continue to grow as more people become aware of the disorder and seek treatment. Companies in the Attention Deficit Disorder market include Shire Pharmaceuticals, Novartis, and Eli Lilly. Other companies in the Mental Health market include Pfizer, Johnson & Johnson, and GlaxoSmithKline. Show Less Read more